<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.1.0//EN//XML?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName art510.dtd?>
  <?SourceDTD.Version 5.1.0?>
  <?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <?origin publisher?>
  <?FILEmeta_JHEPAT3374 xml ?>
  <?FILEmain xml ?>
  <?FILEgr1 jpg ?>
  <?FILEgr2 jpg ?>
  <?FILEgr3 jpg ?>
  <?FILEfx1 jpg ?>
  <?FILEfx2 jpg ?>
  <?FILEfx3 jpg ?>
  <?FILEfx4 jpg ?>
  <?FILEmmc1 pdf ?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Hepatol</journal-id>
      <journal-title-group>
        <journal-title>Journal of Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0168-8278</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2956830</article-id>
      <article-id pub-id-type="pmid">20691492</article-id>
      <article-id pub-id-type="publisher-id">JHEPAT3374</article-id>
      <article-id pub-id-type="doi">10.1016/j.jhep.2010.05.016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ferroportin disease: A systematic meta-analysis of clinical and molecular findings<sup><xref ref-type="fn" rid="d29e159">&#x2606;</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mayr</surname>
            <given-names>Roman</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Janecke</surname>
            <given-names>Andreas R.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schranz</surname>
            <given-names>Melanie</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Griffiths</surname>
            <given-names>William J.H.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vogel</surname>
            <given-names>Wolfgang</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pietrangelo</surname>
            <given-names>Antonello</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zoller</surname>
            <given-names>Heinz</given-names>
          </name>
          <email>heinz.zoller@i-med.ac.at</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Medicine II, Gastroenterology and Hepatology, Medical University of Innsbruck, Austria</aff>
      <aff id="aff2"><label>2</label>Department of Pediatrics II, Medical University of Innsbruck, Austria</aff>
      <aff id="aff3"><label>3</label>Department of Hepatology, Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK</aff>
      <aff id="aff4"><label>4</label>Department of Medicine, University Hospital of Modena, Policlinico di Modena, Modena, Italy</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x204E;</label>Corresponding author. Address: Department of Medicine II, Gastroenterology and Hepatology, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria. Tel.: +43 512 504 23397; fax: +43 512 504 23309. <email>heinz.zoller@i-med.ac.at</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <volume>53</volume>
      <issue>5-3</issue>
      <fpage>941</fpage>
      <lpage>949</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>11</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>9</day>
          <month>5</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>5</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xC2;&#xA9; 2010 Elsevier B.V.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>European Association for the Study of the Liver</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background &amp; Aims</title>
          <p><italic>Classical</italic> ferroportin disease is characterized by hyperferritinemia, normal transferrin saturation, and iron overload in macrophages. A <italic>non-classical</italic> form is characterized by additional hepatocellular iron deposits and a high transferrin saturation. Both forms demonstrate autosomal dominant transmission and are associated with ferroportin gene (<italic>SLC40A1</italic>) mutations. <italic>SLC40A1</italic> encodes a cellular iron exporter expressed in macrophages, enterocytes, and hepatocytes. The aim of the analysis is to determine the penetrance of <italic>SLC40A1</italic> mutations and to evaluate <italic>in silico</italic> tools to predict the functional impairment of ferroportin mutations as an alternative to <italic>in vitro</italic> studies.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We conducted a systematic review of the literature and meta-analysis of the biochemical presentation, genetics, and pathology of ferroportin disease.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Of the 176 individuals reported with <italic>SLC40A1</italic> mutations, 80 were classified as <italic>classical</italic> phenotype with hyperferritinemia and normal transferrin saturation. The <italic>non-classical</italic> phenotype with hyperferritinemia and elevated transferrin saturation was present in 53 patients. The remaining patients had normal serum ferritin or the data were reported incompletely. Despite an increased hepatic iron concentration in all biopsied patients, significant fibrosis or cirrhosis was present in only 11%. Hyperferritinemia was present in 86% of individuals with ferroportin mutations. Bio-informatic analysis of ferroportin mutations showed that the PolyPhen score has a sensitivity of 99% and a specificity of 67% for the discrimination between ferroportin mutations and polymorphisms.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>In contrast to HFE hemochromatosis, ferroportin disease has a high penetrance, is genetically heterogeneous and is rarely associated with fibrosis. <italic>Non-classical</italic> ferroportin disease is associated with a higher risk of fibrosis and a more severe overload of hepatic iron.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>AUROC, area under the receiver operator curve</kwd>
        <kwd>ER, endoplasmic reticulum</kwd>
        <kwd>HIC, hepatic iron concentration</kwd>
        <kwd>JAK2, Janus Kinase 2</kwd>
        <kwd>MRI, magnetic resonance imaging</kwd>
        <kwd>PolyPhen, polymorphism phenotyping</kwd>
        <kwd>ROC, receiver operator curve</kwd>
        <kwd>SIFT, sorting intolerant from tolerant</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>SLC40A1</kwd>
        <kwd>Hemochromatosis type IV</kwd>
        <kwd>Iron</kwd>
        <kwd>Bio-informatics</kwd>
        <kwd>SLC11A3</kwd>
        <kwd>IREG1</kwd>
        <kwd>FPN1</kwd>
        <kwd>PolyPhen</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Ferroportin disease is a clinically and genetically heterogeneous iron overload syndrome <xref rid="bib1" ref-type="bibr">[1]</xref>. Its clinical presentation has been documented in individual case reports and small case series. The natural course has been reported in one small series <xref rid="bib2" ref-type="bibr">[2]</xref>. Hyperferritinemia, a normal to low transferrin saturation and Kupffer cell iron storage, presenting as hepatic and spleen iron overload, are considered characteristic features of <italic>classical</italic> ferroportin disease <xref rid="bib3" ref-type="bibr">[3]</xref>. Increased transferrin saturation and hepatocellular iron overload, in addition to hyperferritinemia and macrophage iron loading, is considered characteristic for the <italic>non-classical</italic> phenotype <xref rid="bib3 bib4" ref-type="bibr">[3,4]</xref>.</p>
      <p>A genotype&#x2013;phenotype correlation was suggested to explain the clinical heterogeneity of the disease where most mutations (e.g. A77D, D157G, V162del, N174I, Q182H, Q248H, and G323V) are associated with <italic>classical</italic> ferroportin disease <xref rid="bib5 bib6 bib7 bib8" ref-type="bibr">[5&#x2013;8]</xref>. Distinct mutations (e.g. N144H, Y64N, C326Y/S, S338R, Y501C) have been found in patients who presented with the <italic>non-classical</italic> phenotype <xref rid="bib5 bib9 bib10 bib11 bib12" ref-type="bibr">[5,9&#x2013;12]</xref>.</p>
      <p>Ferroportin is the only known mammalian iron exporter and is expressed in macrophages and the basolateral membrane of enterocytes and hepatocytes <xref rid="bib13 bib14 bib15" ref-type="bibr">[13&#x2013;15]</xref>. In <italic>classical</italic> ferroportin disease, macrophage iron overload results from cellular iron export deficiency, i.e. loss of ferroportin function <xref rid="bib6" ref-type="bibr">[6]</xref>. The D157G mutation leads to hepcidin-independent, constitutive binding of Janus Kinase 2 (JAK2) and thus triggers ferroportin down-regulation <xref rid="bib16" ref-type="bibr">[16]</xref>. The concept that other loss of function mutations of ferroportin result in intracellular retention of the iron export pump has been challenged recently <xref rid="bib17 bib18" ref-type="bibr">[17,18]</xref>, but alternative mechanisms leading to iron transport deficiency have not been fully elucidated.</p>
      <p>Ferroportin inactivation is mediated by the peptide hormone hepcidin <xref rid="bib19 bib20" ref-type="bibr">[19,20]</xref>. Distinct mutations render ferroportin resistant to inactivation by hepcidin and cause a gain of iron export function, which results in hyper-absorption of dietary iron.</p>
      <p>Hepcidin is secreted by hepatocytes into the circulation in response to pro-inflammatory cytokines, hepatocellular iron loading, and endoplasmic reticulum stress <xref rid="bib21 bib22" ref-type="bibr">[21,22]</xref>. Circulating hepcidin directly interacts with ferroportin and induces its internalization and degradation <xref rid="bib23" ref-type="bibr">[23]</xref>. The free thiol group of cysteine 326 of ferroportin is essential for hepcidin binding and ferroportin gene mutations affecting residue 326 result in hepcidin resistance <xref rid="bib7 bib24" ref-type="bibr">[7,24]</xref>. Patients with ferroportin disease due to hepcidin resistance mutations, exhibit a <italic>non-classical</italic> phenotype <xref rid="bib8 bib25 bib26" ref-type="bibr">[8,25,26]</xref>.</p>
      <p>Functional studies in cells overexpressing ferroportin variants have been used to differentiate between gain-of-function and loss-of-function mutations and benign sequence variants. The functional relevance of ferroportin mutations can also be deduced from mutation segregation studies within families with ferroportin disease. Association studies of <italic>SLC40A1</italic> polymorphisms with serum iron indices in population studies indirectly provide evidence for their functional relevance <xref rid="bib27 bib28 bib29" ref-type="bibr">[27&#x2013;29]</xref>.</p>
      <p>Bio-informatic tools were used to complement the genetic and functional studies. SIFT <xref rid="bib30" ref-type="bibr">[30]</xref> and PolyPhen <xref rid="bib31" ref-type="bibr">[31]</xref> provide an <italic>in silico</italic> prediction of the functional consequences of missense mutations. The use of these tools in differentiating between diseases-associated ferroportin mutations from benign sequence variants was assessed. The clinical presentation and penetrance of ferroportin gene mutations were assessed from a systematic review of the literature.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Search strategy</title>
        <p>A systematic literature search was undertaken in Medline from 1996 to June 2009 according to the following search strategy: #1 (&#x2018;<italic>SLC40A1</italic>&#x2019; or &#x2018;SLC11A3&#x2019; or &#x2018;ferroportin&#x2019; or &#x2018;IREG&#x2019; or &#x2018;IREG1&#x2019; or &#x2018;IREG-1&#x2019; or &#x2018;ferroportin&#x2019; or &#x2018;ferroportin1&#x2019; or &#x2018;ferroportin-1&#x2019; or &#x2018;FPN&#x2019; or &#x2018;FPN1&#x2019; or &#x2018;FPN-1&#x2019;).mp. [mp&#xA0;=&#xA0;title, original title, abstract, name of substance word, subject heading word]; #2 (&#x2018;mutation&#x2019; or &#x2018;variant&#x2019;).mp. [mp&#xA0;=&#xA0;title, original title, abstract, name of substance word, subject heading word]; # 3: #1 and #2. This search retrieved 143 references and was supplemented by manual searching for references of the relevant articles identified. After exclusion of review articles and non-human studies, data from 49 studies were included. This search was complemented by an Embase search using the search strategy: #1 (?<italic>SLC40A1</italic>? or ?SLC11A3? or ?ferroportin? or ?IREG? or ?IREG1? or ?IREG-1? or ?ferroportin? or ?ferroportin1? or ?ferroportin-1? or ?FPN? or ?FPN1? or ?FPN-1?).mp. [mp&#xA0;=&#xA0;title, original title, abstract, name of substance word, subject heading word]; #2 (?mutation? or ?variant?).mp. [mp&#xA0;=&#xA0;title, original title, abstract, name of substance word, subject heading word]; # 3: #1 and #2.</p>
      </sec>
      <sec>
        <title>Prediction of the functional effect of amino acid substitutions by <italic>in silico</italic> analysis</title>
        <p>Two algorithms were used to evaluate the impact of amino acid substitutions on the function of ferroportin: polymorphism phenotyping (PolyPhen) <xref rid="bib31 bib32 bib33" ref-type="bibr">[31&#x2013;33]</xref> and sorting intolerant from tolerant (SIFT) <xref rid="bib30" ref-type="bibr">[30]</xref>. Genetic variants of SLC40A1, identified in patients with suspected iron overload, were collected from the systematic review of the literature. In addition, single nucleotide polymorphisms of SLC40A1 were collected from the literature and from ENSEMBL (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/">http://www.ensembl.org/</ext-link>) and the NCBI databases (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>). A SLC40A1 variant was considered a mutation in case its frequency in the control population was undetermined, or lower than 1:50, and the variant was not reported in a SNP database <xref rid="bib27 bib28 bib29 bib34 bib35" ref-type="bibr">[27&#x2013;29,34,35]</xref>.</p>
      </sec>
      <sec>
        <title>PolyPhen</title>
        <p>PolyPhen (=&#xA0;<italic>Poly</italic>morphism <italic>Phen</italic>otyping) is an automatic tool for prediction of possible impact of an amino acid substitution on the structure and function of a human protein. The predictive value of the PolyPhen score was demonstrated in <italic>diabetes mellitus</italic> <xref rid="bib36" ref-type="bibr">[36]</xref> and cancer genetics <xref rid="bib37" ref-type="bibr">[37]</xref>. This prediction is based on empirical rules which are applied to the sequence, phylogenetic, and structural information characterizing the substitution <xref rid="bib31" ref-type="bibr">[31]</xref>. PolyPhen was employed, as available at <ext-link ext-link-type="uri" xlink:href="http://coot.embl.de/PolyPhen/">http://coot.embl.de/PolyPhen/</ext-link> (version August 12, 2008), using the NCBI protein accession number <ext-link ext-link-type="uri" xlink:href="ncbi-p:Q9NP59">Q9NP59</ext-link> (<italic>SLC40A1</italic>) for ferroportin. In all cases, the prediction basis was only the default position-specific independent counts (PSIC) score derived from multiple sequence alignment of observations. PolyPhen scores of &gt;2.0 indicated protein function as &#x2018;probably damaging&#x2019; and scores of &lt;1.5 as &#x2018;benign&#x2019;. A PolyPhen score of 1.5&#x2013;2.0 is classified as &#x2018;possibly&#x2019; damaging.</p>
        <p>A phylogenetic sequence alignment of selected ferroportin protein sequences is shown in <xref rid="fig2" ref-type="fig">Fig. 2</xref>.</p>
      </sec>
      <sec>
        <title>SIFT</title>
        <p>SIFT (=&#xA0;Sorting Intolerant from Tolerant) is a sequence-homology-based tool that presumes that important amino acids will be conserved in the protein family. Changes at well-conserved positions tend to be predicted as deleterious. SIFT is a multi-step procedure that uses multiple alignment information to predict tolerated and deleterious substitutions for every position of the query sequence <xref rid="bib30" ref-type="bibr">[30]</xref>. The SIFT Blink algorithm was applied to compare amino acid sequences of different organisms chosen from precomputed NCBI BLAST searches. For query in SIFT Blink, GI: 49065554 (<italic>SLC40A1</italic>) was used to analyze the protein sequence by using the parameter &#x2018;best BLAST hit to each organism&#x2019; and omitting sequences &gt;90% identical to query. Edited alignments were reanalyzed by the appropriate module of SIFT (<ext-link ext-link-type="uri" xlink:href="http://blocks.fhcrc.org/sift/SIFT_aligned_seqs_submit.html">http://blocks.fhcrc.org/sift/SIFT_aligned_seqs_submit.html</ext-link>). Results were reported as &#x2018;affects protein function&#x2019; or &#x2018;tolerated&#x2019; according to this analysis.</p>
        <p>To evaluate the bio-informatic tools to distinguish between benign and disease sequence variants, the SLC40A1 polymorphisms were used as true negatives and genetic variants of SLC40A1 identified in patients with ferroportin disease as true positives. The PolyPhen and SIFT scores were then analyzed in a ROC curve for their sensitivity and specificity.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>For statistical analysis the software package for social sciences (SPSS v15.0) was used. To test for correlation between parameters, Pearson correlation was carried out for normally distributed parameters and Spearman rank correlation for non-normally distributed parameters. Normality of distribution was tested by Kolmogorov&#x2013;Smirnov curve-fitting. Differences between groups were analyzed by Kruskal Wallis test for non-Gaussian distributed variables. Correlations and differences were considered significant if <italic>p</italic> &lt;0.05. Sensitivity and specificity of SIFT and PolyPhen scores were calculated form the ROC curve analysis using mutations identified in patients with ferroportin disease as true positives and polymorphisms reported in the SNP database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/sites/entrez">http://www.ncbi.nlm.nih.gov/sites/entrez</ext-link>) as true negatives.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>High biochemical penetrance and variable clinical presentation of SLC40A1 mutations</title>
        <p>One hundred and seventy-six individuals with ferroportin gene mutations were reported in the literature, and their demographic and biochemical data are listed in <xref rid="tbl1" ref-type="table">Table 1</xref>. The diagnosis of ferroportin disease was most frequently made in the 3rd to 4th decade of life and 43% of patients were female.</p>
        <p>To describe the disease presentation and the penetrance of underlying mutations, serum iron parameters, liver biopsy findings, MRI, comorbidities, and phlebotomy status were assessed. These were reported incompletely for several patients (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
        <p>Forty-five comorbidities were reported in 29 patients (viral hepatitis 3, steatosis 12, obesity 5, diabetes 8, impaired glucose tolerance 2, hyperlipidemia 2, increased alcohol consumption 2, and sarcoidosis 2). Mean age and mean serum ferritin were significantly higher in patients with comorbidities, than in patients without comorbidities, (52&#xA0;&#xB1;&#xA0;15&#xA0;years vs. 39&#xA0;&#xB1;&#xA0;20&#xA0;years <italic>p&#xA0;</italic>=&#xA0;0.002 and 3133&#xA0;&#xB1;&#xA0;3270&#xA0;&#x3BC;g/L vs. 1965&#xA0;&#xB1;&#xA0;2067&#xA0;&#x3BC;g/L, <italic>p&#xA0;</italic>=&#xA0;0.017). Fibrosis &#x2A7E;F1 (Metavir) was significantly more common in patients with comorbidities than in patients without comorbidities (12 of 44 vs. 10 of 18; Fisher&#x2019;s exact test <italic>p</italic> &lt;0.05).</p>
        <p>The biochemical penetrance of ferroportin disease was 86% (142 of 166 patients), defined as hyperferritinemia &gt;300&#xA0;&#x3BC;g/L in males and &gt;200&#xA0;&#x3BC;g/L in females. We found a significant correlation between serum ferritin and age (<italic>r</italic><sup>2</sup>&#xA0;=&#xA0;0.344, <italic>n</italic>&#xA0;=&#xA0;158, <italic>p</italic> &lt;0.001). The phenotype of hyperferritinemic patients was classified as <italic>classical</italic> if transferrin saturation was normal and as <italic>non-classical</italic> if transferrin saturation was increased (males &gt;50%, females &gt;45%). <italic>Classical</italic> disease was present in 80 patients as opposed to 53 patients with <italic>non-classical</italic> disease, whose mean age at presentation was significantly higher (44 vs. 37 years, <italic>p</italic> &lt;0.05) (<xref rid="tbl2" ref-type="table">Table 2</xref>). Serum iron parameters for the remaining 43 patients were either incompletely reported or normal (16 patients). Differences between <italic>classical</italic> and <italic>non-classical</italic> phenotype are evident in <xref rid="tbl2" ref-type="table">Table 2</xref> where mean hemoglobin, ferritin, and hepatic iron concentration (HIC) were significantly lower in the <italic>classical</italic> disease cohort.</p>
        <p>Liver iron was increased in 30 of 31 reported patients, with a mean HIC of 310&#xA0;&#x3BC;mol/g (normal &lt;25&#xA0;&#x3BC;mol/g) <xref rid="bib38" ref-type="bibr">[38]</xref>. Liver fibrosis &#x2A7E;F2 or liver cirrhosis was present in 7 of 53 biopsied patients (13%), and correlated with age (mean 53.3 vs. 36.2&#xA0;years, <italic>p</italic> &lt;0.001). Cirrhosis was reported in 4 of 176 patients, of whom 2 had the N144H mutation, one patient the C326S and one the I180T mutation <xref rid="bib25 bib39 bib40" ref-type="bibr">[25,39,40]</xref>. One patient with ferroportin disease was diagnosed with hepatocellular carcinoma which was possibly linked with occult hepatitis B virus infection <xref rid="bib2" ref-type="bibr">[2]</xref>.</p>
        <p>In search of factors that discriminate ferroportin disease severity, the correlation between patient demographics, serum iron parameters, and liver biopsy findings was determined. The stage of liver fibrosis correlated significantly with age (<italic>r</italic>&#xA0;=&#xA0;0.54, <italic>n</italic>&#xA0;=&#xA0;53, <italic>p</italic> &lt;0.001), but neither with HIC nor with serum ferritin. HIC and transferrin saturation (<italic>r</italic>&#xA0;=&#xA0;0.528, <italic>p&#xA0;</italic>=&#xA0;0.003, <italic>n</italic>&#xA0;=&#xA0;29), and HIC and serum ferritin (<italic>r</italic>&#xA0;=&#xA0;0.423, <italic>p&#xA0;</italic>=&#xA0;0.018, <italic>n</italic>&#xA0;=&#xA0;31) showed a moderate correlation.</p>
      </sec>
      <sec>
        <title>Genotype&#x2013;phenotype correlation partly explains variability in clinical presentation</title>
        <p>Of 31 <italic>SLC40A1</italic> mutations, 6 and 5 were unequivocally associated with the <italic>classical</italic> or the <italic>non-classical</italic> phenotype, respectively (<xref rid="tbl2" ref-type="table">Table 2</xref>). Variable phenotypes in individual patients with the same mutation were reported for 9 mutations (<xref rid="fig1" ref-type="fig">Fig. 1</xref> and <xref rid="tbl3" ref-type="table">Table 3</xref>).</p>
        <p>MRI findings of liver and spleen iron were reported for 8 ferroportin mutations (c.-188A&gt;G, G490D, I152F, L233P, R178G, V162del, Y64&#xA0;N, Y501C) <xref rid="bib12 bib41 bib42 bib43 bib44 bib45 bib5 bib46" ref-type="bibr">[12,41&#x2013;45,5,46]</xref> where the small number of patients prohibits assessment of the diagnostic performance of MRI for the classification of ferroportin disease.</p>
      </sec>
      <sec>
        <title>How to differentiate between SLC40A1 mutations and polymorphisms</title>
        <p>Ferroportin disease is genetically heterogeneous with 36 different <italic>SLC40A1</italic> mutations reported <xref rid="bib8 bib9 bib10 bib12 bib26 bib27 bib28 bib29 bib38 bib39 bib40 bib41 bib45 bib46 bib47 bib48 bib49 bib50 bib51 bib52 bib53 bib54 bib55 bib56 bib57 bib58 bib59 bib60 bib61 bib62 bib63 bib64 bib65 bib66 bib67 bib68" ref-type="bibr">[8&#x2013;10,12,26&#x2013;29,38&#x2013;41,45&#x2013;68]</xref> as summarized in <xref rid="tbl3" ref-type="table">Table 3</xref>. In addition, 9 ferroportin gene polymorphisms were reported, 3 of which were associated with increased serum ferritin in various populations (<xref rid="tbl4" ref-type="table">Table 4</xref>) <xref rid="bib29 bib34" ref-type="bibr">[29,34]</xref>. The allele frequencies of 29 disease-associated ferroportin mutations had been determined in matched populations and was found to be &lt;1:100. It remains unclear whether L233V and D270P, each of which have been identified in single patients with iron overload, are disease-causing mutations or represent benign sequence variants <xref rid="bib43 bib65" ref-type="bibr">[43,65]</xref>.</p>
        <p>To determine whether bio-informatic tools PolyPhen and SIFT <xref rid="bib30 bib32 bib69" ref-type="bibr">[30,32,69]</xref> can discriminate between disease-causing <italic>SLC40A1</italic> mutations and benign sequence variants, their ability to classify known ferroportin sequence variants accordingly was tested. The predicted functional impairment of individual sequence variants from the PolyPhen and SIFT tools were used as outcome variables for a receiver-operator curve analysis. The PolyPhen score had a high diagnostic accuracy with a calculated area under the ROC curve (AUROC) of 0.798 (<italic>p&#xA0;</italic>=&#xA0;0.014) (<xref rid="fig3" ref-type="fig">Fig. 3</xref>). Using the descriptive output of PolyPhen (i.e. probably damaging, possibly damaging or benign) as predictors of the functional consequence of particular gene variants, the sensitivity of the PolyPhen score was 99% and the specificity 67% (<xref rid="tbl2" ref-type="table">Table 2</xref> and <xref rid="fig3" ref-type="fig">Fig. 3</xref>). SIFT analysis predicted that 23 of 32 disease associated missense mutations &#x2018;affects&#x2019; protein function and 9 are &#x2018;tolerated&#x2019;. Of 9 reported polymorphisms 7 were classified as &#x2018;tolerated&#x2019; (AUROC 0.605 <italic>p&#xA0;</italic>=&#xA0;0.37). The bio-informatics PolyPhen tool has a higher sensitivity and specificity than the SIFT score for the discrimination between missense mutations and single nucleotide polymorphisms of <italic>SLC40A1</italic>.</p>
        <p>Serum ferritin concentration (<italic>r</italic>&#xA0;=&#xA0;0.226, <italic>n</italic>&#xA0;=&#xA0;136, <italic>p&#xA0;</italic>=&#xA0;0.008), and transferrin saturation (<italic>r</italic>&#xA0;=&#xA0;0.198, <italic>n</italic>&#xA0;=&#xA0;128, <italic>p&#xA0;</italic>=&#xA0;0.025) were correlated with the PolyPhen score, suggesting that ferroportin disease is more severe when phylogenetically more conserved residues are affected by the mutation.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Ferroportin disease is the commonest genetic iron overload syndrome after HFE associated hemochromatosis and has a variable clinical presentation. This review of the literature and meta-analysis shows that hyperferritinemia and increased hepatic iron concentration are characteristic signs of the disease. In contrast, elevated transferrin saturation and splenic iron overload are variably present. Hyperferritinemia was found in 86% of individual with ferroportin mutations, but incomplete reporting is a limitation for the accurate assessment of disease penetrance. The observed correlation between age and serum ferritin supports the concept that ferroportin disease is a progressive iron overload disorder. It is therefore possible that patients detected through cross-sectional study designs have not yet had time to develop the &#x2018;full-blown&#x2019; disease. Hence, it is difficult to assess the true penetrance without further follow-up data. By comparison, in genetic hemochromatosis hyperferritinemia was present in 55&#x2013;86% of <italic>C282Y</italic> homozygotes <xref rid="bib70 bib71" ref-type="bibr">[70,71]</xref> and cirrhosis was present in 36% of more severely affected <italic>C282Y</italic> homozygous individuals with ferritin &gt;1000&#xA0;&#x3BC;g/L <xref rid="bib72" ref-type="bibr">[72]</xref>.</p>
      <p>To assess the pathology of ferroportin disease, the findings of liver biopsies were reviewed. However, liver biopsies were performed in only a few patients and the results were inconsistently reported. This prohibits a systematic classification of ferroportin disease based on liver biopsy results. In patients who underwent liver biopsies for ferroportin disease, hepatic iron concentration was invariably increased and the penetrance of liver fibrosis &#x2A7E;F2 was 13%. Age, hepatic iron concentration, and comorbidities were associated with fibrosis stage and are thus potential risk factors for fibrosis in ferroportin disease.</p>
      <p>A simple biochemical classification strategy based on transferrin saturation was used as an alternative to liver biopsy. Transferrin saturation is low to normal in <italic>classical</italic> ferroportin disease and increased in patients with the <italic>non-classical</italic> phenotype. An arbitrary threshold for transferrin saturation of 45% for females and 50% for males was used to distinguish <italic>classical</italic> from the <italic>non-classical</italic> phenotype. The value of this simple classification is supported by our meta-analysis, which shows that patients with the <italic>classical</italic> phenotype have lower hemoglobin concentrations. This may explain why patients with <italic>classical</italic> ferroportin disease appear to tolerate therapeutic venesection less well than hemochromatosis patients. MRI was proposed as an alternative to liver biopsy to discriminate between <italic>classical</italic> and <italic>non-classical</italic> ferroportin disease. However, no correlation between parameters of disease severity and MRI findings has been reported <xref rid="bib73" ref-type="bibr">[73]</xref>.</p>
      <p>The genotype to phenotype correlation suggests that ferroportin disease has a multifactorial cause because not all mutations were unambiguously correlated with the <italic>classical</italic> or <italic>non-classical</italic> phenotype in all reported patients with a particular mutation. Our meta-analysis suggests that Y64N, V72F, and Y501C confer hepcidin resistance because the phenotypic presentation as <italic>non-classical</italic> disease is similar to the C326Y mutation <xref rid="bib7 bib74 bib75" ref-type="bibr">[7,74,75]</xref>. Similarly, <italic>classical</italic> mutations D157N, D181V, G80V, Q182H, R489K, and V162del may impair the iron export function of ferroportin through incorrect folding, subcellular mislocalization, or direct inhibition of the iron transport function <xref rid="bib6 bib18 bib75" ref-type="bibr">[6,18,75]</xref>.</p>
      <p>We have assessed PolyPhen and SIFT <xref rid="bib76" ref-type="bibr">[76]</xref> as alternatives to predict the effect of ferroportin mutations on protein function, because functional studies of ferroportin mutants <xref rid="bib6 bib17 bib18 bib68 bib75" ref-type="bibr">[6,17,18,68,75]</xref> have shown conflicting results <xref rid="bib17 bib18" ref-type="bibr">[17,18]</xref>. Our analysis shows that PolyPhen is a sensitive tool to identify disease-causing gene variants by classifying mutations identified in patients with iron overload as &#x2018;possibly&#x2019; or &#x2018;probably&#x2019; damaging. The sensitivity of the PolyPhen score is 99% and the specificity 67%. These findings suggest that the functional effect of ferroportin mutations can be predicted <italic>in silico</italic> and that these tools may help to interpret the relevance of newly-identified mutations in the future.</p>
      <p>The systematic review of the molecular genetics and the clinical presentation of ferroportin disease highlights the heterogeneity of the disease and the difficulties in securing the diagnosis. Similar to <italic>HFE</italic> hemochromatatosis, age, and comorbidities appear to be important risk factors for the development of fibrosis in patients with ferroportin disease <xref rid="bib77" ref-type="bibr">[77]</xref>. PolyPhen helps to score newly-identified, presumed <italic>SLC40A1</italic> mutations; identification of a genetic variant in <italic>SLC40A1</italic> is not sufficient to confirm ferroportin disease in patients with hyperferritinemia.</p>
    </sec>
    <sec>
      <title>Conflict of interest</title>
      <p>The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ponka</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Rare causes of hereditary iron overload</article-title>
          <source>Semin Hematol</source>
          <volume>39</volume>
          <year>2002</year>
          <fpage>249</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">12382200</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corradini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Pollicino</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Vegetti</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Abbati</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Losi</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Disease progression and liver cancer in the ferroportin disease</article-title>
          <source>Gut</source>
          <volume>56</volume>
          <year>2007</year>
          <fpage>1030</fpage>
          <lpage>1032</lpage>
          <pub-id pub-id-type="pmid">17566043</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pietrangelo</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>The ferroportin disease</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>32</volume>
          <year>2004</year>
          <fpage>131</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">14757427</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoller</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>T.M.</given-names>
            </name>
          </person-group>
          <article-title>Hemochromatosis: genetic testing and clinical practice</article-title>
          <source>Clin Gastroenterol Hepatol</source>
          <volume>3</volume>
          <year>2005</year>
          <fpage>945</fpage>
          <lpage>958</lpage>
          <pub-id pub-id-type="pmid">16234038</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drakesmith</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schimanski</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Ormerod</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Viprakasit</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin</article-title>
          <source>Blood</source>
          <volume>106</volume>
          <year>2005</year>
          <fpage>1092</fpage>
          <lpage>1097</lpage>
          <pub-id pub-id-type="pmid">15831700</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schimanski</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Drakesmith</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Viprakasit</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Sweetland</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations</article-title>
          <source>Blood</source>
          <volume>105</volume>
          <year>2005</year>
          <fpage>4096</fpage>
          <lpage>4102</lpage>
          <pub-id pub-id-type="pmid">15692071</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Domenico</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Nemeth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Ajioka</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>The hepcidin-binding site on ferroportin is evolutionarily conserved</article-title>
          <source>Cell Metabol</source>
          <volume>8</volume>
          <year>2008</year>
          <fpage>146</fpage>
          <lpage>156</lpage>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lok</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Viprakasit</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Chinthammitr</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Srichairatanakool</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Limwongse</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Iron overload in the Asian community</article-title>
          <source>Blood</source>
          <volume>114</volume>
          <year>2009</year>
          <fpage>20</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">19342478</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Ramm</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>L.W.</given-names>
            </name>
            <name>
              <surname>Subramaniam</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>A novel mutation in ferroportin implicated in iron overload</article-title>
          <source>J Hepatol</source>
          <volume>46</volume>
          <year>2007</year>
          <fpage>921</fpage>
          <lpage>926</lpage>
          <pub-id pub-id-type="pmid">17383046</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viprakasit</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Chinthammitr</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Schimanski</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Drakesmith</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Srichairatanakool</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Molecular diagnosis of the first ferroportin mutation (C326Y) in the Far East causing a dominant form of inherited iron overload</article-title>
          <source>ASH Annu Meeting Abstr</source>
          <volume>104</volume>
          <year>2004</year>
          <fpage>3204</fpage>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sham</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Phatak</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>Nemeth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ganz</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation</article-title>
          <source>Blood</source>
          <volume>114</volume>
          <year>2009</year>
          <fpage>493</fpage>
          <lpage>494</lpage>
          <pub-id pub-id-type="pmid">19589941</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Letocart</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Le Gac</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Majore</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ka</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Radio</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Gourlaouen</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases</article-title>
          <source>Br J Haematol</source>
          <volume>147</volume>
          <year>2009</year>
          <fpage>379</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="pmid">19709084</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donovan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brownlie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pratt</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Moynihan</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter</article-title>
          <source>Nature</source>
          <volume>403</volume>
          <year>2000</year>
          <fpage>776</fpage>
          <lpage>781</lpage>
          <pub-id pub-id-type="pmid">10693807</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKie</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Marciani</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Rolfs</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Wehr</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Barrow</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation</article-title>
          <source>Mol Cell</source>
          <volume>5</volume>
          <year>2000</year>
          <fpage>299</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">10882071</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abboud</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Haile</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>A novel mammalian iron-regulated protein involved in intracellular iron metabolism</article-title>
          <source>J Biol Chem</source>
          <volume>275</volume>
          <year>2000</year>
          <fpage>19906</fpage>
          <lpage>19912</lpage>
          <pub-id pub-id-type="pmid">10747949</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Domenico</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin downregulation</article-title>
          <source>Blood</source>
          <volume>115</volume>
          <year>2010</year>
          <fpage>2956</fpage>
          <lpage>2959</lpage>
          <pub-id pub-id-type="pmid">20124516</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rice</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Mendez</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Hokanson</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Rees</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Bjorkman</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter</article-title>
          <source>J Mol Biol</source>
          <volume>386</volume>
          <year>2009</year>
          <fpage>717</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="pmid">19150361</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Subramaniam</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <volume>298</volume>
          <year>2010</year>
          <fpage>C75</fpage>
          <lpage>C84</lpage>
          <pub-id pub-id-type="pmid">19846751</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pigeon</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ilyin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Courselaud</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Leroyer</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Turlin</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Brissot</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload</article-title>
          <source>J Biol Chem</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>7811</fpage>
          <lpage>7819</lpage>
          <pub-id pub-id-type="pmid">11113132</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Valore</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Waring</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ganz</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Hepcidin, a urinary antimicrobial peptide synthesized in the liver</article-title>
          <source>J Biol Chem</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>7806</fpage>
          <lpage>7810</lpage>
          <pub-id pub-id-type="pmid">11113131</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gelbart</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Beutler</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <volume>101</volume>
          <year>2004</year>
          <fpage>9263</fpage>
          <lpage>9265</lpage>
          <pub-id pub-id-type="pmid">15192150</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vecchi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Montosi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lamberti</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>R.J.</given-names>
            </name>
          </person-group>
          <article-title>ER stress controls iron metabolism through induction of hepcidin</article-title>
          <source>Science</source>
          <volume>325</volume>
          <year>2009</year>
          <fpage>877</fpage>
          <lpage>880</lpage>
          <pub-id pub-id-type="pmid">19679815</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nemeth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tuttle</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Powelson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Vaughn</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Donovan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization</article-title>
          <source>Science</source>
          <volume>306</volume>
          <year>2004</year>
          <fpage>2090</fpage>
          <lpage>2093</lpage>
          <pub-id pub-id-type="pmid">15514116</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandes</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Preza</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Phung</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>De Domenico</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ganz</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The molecular basis of hepcidin-resistant hereditary hemochromatosis</article-title>
          <source>Blood</source>
          <volume>114</volume>
          <year>2009</year>
          <fpage>437</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">19383972</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sham</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Phatak</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Beutler</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>34</volume>
          <year>2005</year>
          <fpage>157</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="pmid">15727899</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rivard</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Lanzara</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Grimard</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Carella</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Simard</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ficarella</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Autosomal dominant reticuloendothelial iron overload (HFE type 4) due to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a large French-Canadian family</article-title>
          <source>Haematologica</source>
          <volume>88</volume>
          <year>2003</year>
          <fpage>824</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="pmid">12857562</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordeuk</surname>
              <given-names>V.R.</given-names>
            </name>
            <name>
              <surname>Caleffi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Corradini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>31</volume>
          <year>2003</year>
          <fpage>299</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">14636642</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNamara</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gordeuk</surname>
              <given-names>V.R.</given-names>
            </name>
            <name>
              <surname>MacPhail</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Ferroportin (Q248H) mutations in African families with dietary iron overload</article-title>
          <source>J Gastroenterol Hepatol</source>
          <volume>20</volume>
          <year>2005</year>
          <fpage>1855</fpage>
          <lpage>1858</lpage>
          <pub-id pub-id-type="pmid">16336444</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beutler</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Felitti</surname>
              <given-names>V.J.</given-names>
            </name>
            <name>
              <surname>Gelbart</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>P.L.</given-names>
            </name>
          </person-group>
          <article-title>Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>31</volume>
          <year>2003</year>
          <fpage>305</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">14636643</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Henikoff</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>SIFT: predicting amino acid changes that affect protein function</article-title>
          <source>Nucleic Acids Res</source>
          <volume>31</volume>
          <year>2003</year>
          <fpage>3812</fpage>
          <lpage>3814</lpage>
          <pub-id pub-id-type="pmid">12824425</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sunyaev</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lathe</surname>
              <given-names>W.</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Integration of genome data and protein structures: prediction of protein folds, protein interactions and &#x201C;molecular phenotypes&#x201D; of single nucleotide polymorphisms</article-title>
          <source>Curr Opin Struct Biol</source>
          <volume>11</volume>
          <year>2001</year>
          <fpage>125</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">11179902</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sunyaev</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ramensky</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Lathe</surname>
              <given-names>W.</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Kondrashov</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Prediction of deleterious human alleles</article-title>
          <source>Hum Mol Genet</source>
          <volume>10</volume>
          <year>2001</year>
          <fpage>591</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="pmid">11230178</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramensky</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sunyaev</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Human non-synonymous SNPs: server and survey</article-title>
          <source>Nucleic Acids Res</source>
          <volume>30</volume>
          <year>2002</year>
          <fpage>3894</fpage>
          <lpage>3900</lpage>
          <pub-id pub-id-type="pmid">12202775</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duca</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Delbini</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nava</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Vaja</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Fiorelli</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Cappellini</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload</article-title>
          <source>Am J Hematol</source>
          <volume>84</volume>
          <year>2009</year>
          <fpage>592</fpage>
          <lpage>593</lpage>
          <pub-id pub-id-type="pmid">19610021</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sussman</surname>
              <given-names>N.L.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Dries</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G</article-title>
          <source>Acta Haematol</source>
          <volume>120</volume>
          <year>2008</year>
          <fpage>168</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="pmid">19066423</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Manson</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Buring</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women</article-title>
          <source>BMC Med Genet</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>4</fpage>
          <pub-id pub-id-type="pmid">19149903</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Easton</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Deffenbaugh</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Pruss</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Frye</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wenstrup</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Allen-Brady</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>A systematic genetic assessment of 1433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes</article-title>
          <source>Am J Hum Genet</source>
          <volume>81</volume>
          <year>2007</year>
          <fpage>873</fpage>
          <lpage>883</lpage>
          <pub-id pub-id-type="pmid">17924331</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pelucchi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mariani</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Salvioni</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bonfadini</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Riva</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bertola</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations of the ferroportin gene (SLC40A1): analysis of 56 consecutive patients with unexplained iron overload</article-title>
          <source>Clin Genet</source>
          <volume>73</volume>
          <year>2008</year>
          <fpage>171</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">18177470</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Njajou</surname>
              <given-names>O.T.</given-names>
            </name>
            <name>
              <surname>de Jong</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Berghuis</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Vaessen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Snijders</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Goossens</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>29</volume>
          <year>2002</year>
          <fpage>439</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">12547233</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bach</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Remacha</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Altes</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Barcelo</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Molina</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Baiget</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>36</volume>
          <year>2006</year>
          <fpage>41</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">16257244</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jouanolle</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Douabin-Gicquel</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Halimi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Loreal</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Fergelot</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Delacour</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload</article-title>
          <source>J Hepatol</source>
          <volume>39</volume>
          <year>2003</year>
          <fpage>286</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">12873829</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunat</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Giansily Blaizot</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bismuth</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Blanc</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dereure</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Larrey</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Global sequencing approach for characterizing the molecular background of hereditary iron disorders</article-title>
          <source>Clin Chem</source>
          <volume>53</volume>
          <year>2007</year>
          <fpage>2060</fpage>
          <lpage>2069</lpage>
          <pub-id pub-id-type="pmid">17951290</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Girelli</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>De Domenico</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Bozzini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Campostrini</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Busti</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Castagna</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations</article-title>
          <source>J Hepatol</source>
          <volume>49</volume>
          <year>2008</year>
          <fpage>664</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="pmid">18713659</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Dooley</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Roques</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Grellier</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dhillon</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>A.P.</given-names>
            </name>
          </person-group>
          <article-title>Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del &#x201C;loss of function&#x201D; mutations in ferroportin disease</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>40</volume>
          <year>2008</year>
          <fpage>328</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="pmid">18160317</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zoller</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>McFarlane</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Theurl</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Stadlmann</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nemeth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Oxley</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease</article-title>
          <source>Hepatology</source>
          <volume>42</volume>
          <year>2005</year>
          <fpage>466</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="pmid">15986403</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Speletas</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kioumi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Loules</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hytiroglou</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tsitouridis</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Christakis</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>40</volume>
          <year>2008</year>
          <fpage>353</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="pmid">17997113</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Imanishi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Iwamoto</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene</article-title>
          <source>Intern Med (Tokyo, Japan)</source>
          <volume>44</volume>
          <year>2005</year>
          <fpage>285</fpage>
          <lpage>289</lpage>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corradini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Montosi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Caleffi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Pignatti</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Barelli</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Lack of enterocyte iron accumulation in the ferroportin disease</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>35</volume>
          <year>2005</year>
          <fpage>315</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">16135412</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montosi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Donovan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Totaro</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Garuti</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pignatti</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Cassanelli</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene</article-title>
          <source>J Clin Invest</source>
          <volume>108</volume>
          <year>2001</year>
          <fpage>619</fpage>
          <lpage>623</lpage>
          <pub-id pub-id-type="pmid">11518736</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pietrangelo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Montosi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Totaro</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Garuti</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Conte</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cassanelli</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene</article-title>
          <source>N Engl J Med</source>
          <volume>341</volume>
          <year>1999</year>
          <fpage>725</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="pmid">10471458</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Subramaniam</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>D.H.</given-names>
            </name>
          </person-group>
          <article-title>Ferroportin disease due to the A77D mutation in Australia</article-title>
          <source>Gut</source>
          <volume>54</volume>
          <year>2005</year>
          <fpage>1048</fpage>
          <lpage>1049</lpage>
          <pub-id pub-id-type="pmid">15951560</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Domenico</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>McVey Ward</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Nemeth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ganz</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Corradini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Molecular and clinical correlates in iron overload associated with mutations in ferroportin</article-title>
          <source>Haematologica</source>
          <volume>91</volume>
          <year>2006</year>
          <fpage>1092</fpage>
          <lpage>1095</lpage>
          <pub-id pub-id-type="pmid">16885049</pub-id>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Njajou</surname>
              <given-names>O.T.</given-names>
            </name>
            <name>
              <surname>Vaessen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Oostra</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Heutink</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Van Duijn</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>The hemochromatosis N144H mutation of SLC11A3 gene in patients with type 2 diabetes</article-title>
          <source>Mol Genet Metab</source>
          <volume>75</volume>
          <year>2002</year>
          <fpage>290</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">11914044</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Njajou</surname>
              <given-names>O.T.</given-names>
            </name>
            <name>
              <surname>Vaessen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Joosse</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Berghuis</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>van Dongen</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Breuning</surname>
              <given-names>M.H.</given-names>
            </name>
          </person-group>
          <article-title>A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis</article-title>
          <source>Nat Genet</source>
          <volume>28</volume>
          <year>2001</year>
          <fpage>213</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">11431687</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arden</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Wallace</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Summerville</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Searle</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>G.J.</given-names>
            </name>
          </person-group>
          <article-title>A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient</article-title>
          <source>Gut</source>
          <volume>52</volume>
          <year>2003</year>
          <fpage>1215</fpage>
          <lpage>1217</lpage>
          <pub-id pub-id-type="pmid">12865285</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hetet</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Devaux</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Soufir</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Grandchamp</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Beaumont</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations</article-title>
          <source>Blood</source>
          <volume>102</volume>
          <year>2003</year>
          <fpage>1904</fpage>
          <lpage>1910</lpage>
          <pub-id pub-id-type="pmid">12730114</pub-id>
        </element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cazzola</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cremonesi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Papaioannou</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Soriani</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kioumi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Charalambidou</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3)</article-title>
          <source>Br J Haematol</source>
          <volume>119</volume>
          <year>2002</year>
          <fpage>539</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="pmid">12406098</pub-id>
        </element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Politou</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kalotychou</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Pissia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rombos</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sakellaropoulos</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Papanikolaou</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The impact of the mutations of the HFE gene and of the SLC11A3 gene on iron overload in Greek thalassemia intermedia and beta(s)/beta(thal) anemia patients</article-title>
          <source>Haematologica</source>
          <volume>89</volume>
          <year>2004</year>
          <fpage>490</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="pmid">15075083</pub-id>
        </element-citation>
      </ref>
      <ref id="bib59">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roetto</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Daraio</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Livesey</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pointon</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Barbabietola</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4</article-title>
          <source>Blood</source>
          <volume>100</volume>
          <year>2002</year>
          <fpage>733</fpage>
          <lpage>734</lpage>
          <pub-id pub-id-type="pmid">12123233</pub-id>
        </element-citation>
      </ref>
      <ref id="bib60">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Pedersen</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Stephenson</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Searle</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Powell</surname>
              <given-names>L.W.</given-names>
            </name>
          </person-group>
          <article-title>Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis</article-title>
          <source>Blood</source>
          <volume>100</volume>
          <year>2002</year>
          <fpage>692</fpage>
          <lpage>694</lpage>
          <pub-id pub-id-type="pmid">12091366</pub-id>
        </element-citation>
      </ref>
      <ref id="bib61">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Browett</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kua</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ameratunga</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Subramaniam</surname>
              <given-names>V.N.</given-names>
            </name>
          </person-group>
          <article-title>Identification of ferroportin disease in the Indian subcontinent</article-title>
          <source>Gut</source>
          <volume>54</volume>
          <year>2005</year>
          <fpage>567</fpage>
          <lpage>568</lpage>
          <pub-id pub-id-type="pmid">15753550</pub-id>
        </element-citation>
      </ref>
      <ref id="bib62">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cremonesi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Forni</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Soriani</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lamagna</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Fermo</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Daraio</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Genetic and clinical heterogeneity of ferroportin disease</article-title>
          <source>Br J Haematol</source>
          <volume>131</volume>
          <year>2005</year>
          <fpage>663</fpage>
          <lpage>670</lpage>
          <pub-id pub-id-type="pmid">16351644</pub-id>
        </element-citation>
      </ref>
      <ref id="bib63">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Litvinova</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Ralston</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mattman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lockitch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>35</volume>
          <year>2005</year>
          <fpage>309</fpage>
          <lpage>314</lpage>
          <pub-id pub-id-type="pmid">16111902</pub-id>
        </element-citation>
      </ref>
      <ref id="bib64">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bozzini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Campostrini</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Trombini</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nemeth</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Castagna</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tenuti</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>40</volume>
          <issue>3</issue>
          <year>2008</year>
          <fpage>347</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">18164223</pub-id>
        </element-citation>
      </ref>
      <ref id="bib65">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaahl</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Kotze</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>van der Merwe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Warnich</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload</article-title>
          <source>Hum Genet</source>
          <volume>115</volume>
          <year>2004</year>
          <fpage>409</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">15338274</pub-id>
        </element-citation>
      </ref>
      <ref id="bib66">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Gelbart</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>SLC40A1 c.1402G&#x2192;a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype</article-title>
          <source>Acta Haematol</source>
          <volume>118</volume>
          <year>2007</year>
          <fpage>237</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="pmid">18160816</pub-id>
        </element-citation>
      </ref>
      <ref id="bib67">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koyama</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wakusawa</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yano</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron</article-title>
          <source>Intern Med (Tokyo, Japan)</source>
          <volume>44</volume>
          <year>2005</year>
          <fpage>990</fpage>
          <lpage>993</lpage>
        </element-citation>
      </ref>
      <ref id="bib68">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griffiths</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Mayr</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>McFarlane</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Hermann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Halsall</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Zoller</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation</article-title>
          <source>Hepatology</source>
          <volume>51</volume>
          <year>2009</year>
          <fpage>788</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="pmid">19937651</pub-id>
        </element-citation>
      </ref>
      <ref id="bib69">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Mohrenweiser</surname>
              <given-names>H.W.</given-names>
            </name>
          </person-group>
          <article-title>Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function</article-title>
          <source>Genomics</source>
          <volume>83</volume>
          <year>2004</year>
          <fpage>970</fpage>
          <lpage>979</lpage>
          <pub-id pub-id-type="pmid">15177551</pub-id>
        </element-citation>
      </ref>
      <ref id="bib70">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Tybjaerg-Hansen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Appleyard</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Birgens</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nordestgaard</surname>
              <given-names>B.G.</given-names>
            </name>
          </person-group>
          <article-title>Hemochromatosis mutations in the general population: iron overload progression rate</article-title>
          <source>Blood</source>
          <volume>103</volume>
          <year>2004</year>
          <fpage>2914</fpage>
          <lpage>2919</lpage>
          <pub-id pub-id-type="pmid">15070663</pub-id>
        </element-citation>
      </ref>
      <ref id="bib71">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allen</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Gurrin</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Constantine</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Osborne</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Delatycki</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Nicoll</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Iron-overload-related disease in HFE hereditary hemochromatosis</article-title>
          <source>N Engl J Med</source>
          <volume>358</volume>
          <year>2008</year>
          <fpage>221</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="pmid">18199861</pub-id>
        </element-citation>
      </ref>
      <ref id="bib72">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beaton</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Guyader</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Deugnier</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Moirand</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Chakrabarti</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis</article-title>
          <source>Hepatology</source>
          <volume>36</volume>
          <year>2002</year>
          <fpage>673</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="pmid">12198660</pub-id>
        </element-citation>
      </ref>
      <ref id="bib73">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pietrangelo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Corradini</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Vegetti</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>De Jong</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Luca Abbati</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease</article-title>
          <source>Blood Cells Mol Dis</source>
          <volume>37</volume>
          <year>2006</year>
          <fpage>192</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">17052926</pub-id>
        </element-citation>
      </ref>
      <ref id="bib74">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandes</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Preza</surname>
              <given-names>G.C.</given-names>
            </name>
            <name>
              <surname>Phung</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>De Domenico</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ganz</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The molecular basis of hepcidin-resistant hereditary hemochromatosis</article-title>
          <source>Blood</source>
          <volume>114</volume>
          <year>2009</year>
          <fpage>437</fpage>
          <lpage>443</lpage>
          <pub-id pub-id-type="pmid">19383972</pub-id>
        </element-citation>
      </ref>
      <ref id="bib75">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drakesmith</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schimanski</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Ormerod</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Merryweather-Clarke</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Viprakasit</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Edwards</surname>
              <given-names>J.P.</given-names>
            </name>
          </person-group>
          <article-title>Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin</article-title>
          <source>Blood</source>
          <volume>106</volume>
          <year>2005</year>
          <fpage>1092</fpage>
          <lpage>1097</lpage>
          <pub-id pub-id-type="pmid">15831700</pub-id>
        </element-citation>
      </ref>
      <ref id="bib76">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miltenberger-Miltenyi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schwarzbraun</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Loscher</surname>
              <given-names>W.N.</given-names>
            </name>
            <name>
              <surname>Wanschitz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Windpassinger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Duba</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutations</article-title>
          <source>Eur J Hum Genet</source>
          <volume>17</volume>
          <year>2009</year>
          <fpage>1154</fpage>
          <lpage>1159</lpage>
          <pub-id pub-id-type="pmid">19259128</pub-id>
        </element-citation>
      </ref>
      <ref id="bib77">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olynyk</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>St Pierre</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Britton</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Brunt</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Bacon</surname>
              <given-names>B.R.</given-names>
            </name>
          </person-group>
          <article-title>Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging</article-title>
          <source>Am J Gastroenterol</source>
          <volume>100</volume>
          <issue>4</issue>
          <year>2005</year>
          <fpage>837</fpage>
          <lpage>841</lpage>
          <pub-id pub-id-type="pmid">15784029</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="supplementary-material">
      <title>
        <bold>Supplementary data</bold>
      </title>
      <p>
        <supplementary-material content-type="local-data" id="d29e1065">
          <caption>
            <title>Supplementary Table</title>
            <p>Results from histology, clinical and biochemical data of individual patients from whom a liver biopsy was reported.</p>
          </caption>
          <media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p content-type="acknowledgment">The authors thank Dr. Marion Breitschopf from the Library of the Medical University of Innsbruck for her help with the EMBASE literature search.</p>
    </ack>
    <fn-group>
      <fn id="d29e159">
        <label>&#x2606;</label>
        <p content-type="funding">This work was supported by the Austrian Science Funds FWF Project P19579 to H.Z.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p><bold>Genotype to phenotype correlation of ferroportin disease: patients with ferroportin disease identified from the systematic meta-analysis were grouped according to the <italic>SLC40A1</italic> mutation.</bold> Box-Whisker blots of (A) serum ferritin, and (B) transferrin saturation in mutations reported in more than 5 patients are shown. Boxes represent 25th and 75th percentile, Whiskers range and horizontal lines represent the median. Outliers are shown as circles. Grey, dark blue, and light blue boxes indicate that all patients reported with the respective mutation were classified as <italic>classical</italic>, <italic>non-classical,</italic> or variable biochemical phenotype, respectively, i.e. all patients had low or normal transferrin saturation (grey), increased transferrin saturation (dark blue), or different patients with the same mutation had variable transferrin saturation (light blue). Any outliers are marked with a circle and extreme cases with an asteriks.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Phylogenetic alignment of ferroportin protein sequences of various species: Disease-associated ferroportin gene mutations are highlighted in light blue. Single nucleotide polymorphisms are shown in dark blue.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p><bold>Diagnostic performance analysis (ROC curve) of PolyPhen and SIFT scores for the prediction of the functional consequence of ferroportin gene variants.</bold> Genetic variants of <italic>SLC40A1</italic> reported as polymorphisms were used as true negatives and genetic variants of <italic>SLC40A1</italic> identified in patients with ferroportin disease were used as true positives. ROC curves are shown with the sensitivity plotted along the abscissa, and 1 &#x2013; specificity plotted along the ordinate.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p><bold>Summary of demographics and clinical characteristics of 176 patients with ferroportin disease</bold>. (Note not all parameters were reported for each patient.)</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td>
              <inline-graphic xlink:href="fx1.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>&#x2217;Phlebotomy was reported for 82 patients. Grams iron removed was reported for 20 patients.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl2" position="float">
      <label>Table 2</label>
      <caption>
        <p><bold>Characteristics of <italic>classical</italic> vs. <italic>non-classical</italic> phenotype of ferroportin disease as defined by the presence of hyperferritinemia with normal transferrin saturation (<italic>classical</italic>) versus patients with hyperferritinemia and elevated transferrin saturation (<italic>non-classical</italic>)</bold>. Data are shown as means&#xA0;&#xB1;&#xA0;standard deviation. Differences were tested for significance using student&#x2019;s <italic>t</italic>-test.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td>
              <inline-graphic xlink:href="fx2.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="tbl3" position="float">
      <label>Table 3</label>
      <caption>
        <p><bold>Molecular genetics of <italic>SLC40A1</italic> mutations.</bold> The frequency of mutations highlighted with &#x2217; in the control population can be inferred from studies, in which control populations have been screened for the presence of another mutation, affecting the same residue.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td>
              <inline-graphic xlink:href="fx3.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>&#x2217;&#x2217;Predicted G468S.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tbl4" position="float">
      <label>Table 4</label>
      <caption>
        <p><bold><italic>SLC40A1</italic> non-synonymous single nucleotide polymorphisms.</bold> SNPs, which have been associated with high serum iron parameters are highlighted in bold and italics.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td>
              <inline-graphic xlink:href="fx4.gif"/>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><sup>a</sup>As reported in the NCBI SNP database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?chooseRs=coding&amp;go=Go&amp;locusId=30061">http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?chooseRs=coding&amp;go=Go&amp;locusId=30061</ext-link>).</p>
          <p><sup>b</sup><ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/Homo_sapiens/Variation/Summary?v=ENSSNP12180430;vdb=variation">http://www.ensembl.org/Homo_sapiens/Variation/Summary?v=ENSSNP12180430;vdb=variation</ext-link>.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
